Abstract
Vaccination is still the most cost-effective way to combat infectious illnesses. Conventional vaccinations may have low immunogenicity and, in most situations, only provide partial protection. A new class of nanoparticle-based vaccinations has shown considerable promise in addressing the majority of the shortcomings of traditional and subunit vaccines. This is due to recent breakthroughs in chemical and biological engineering, which allow for the exact regulation of nanoparticle size, shape, functionality, and surface characteristics, resulting in improved antigen presentation and robust immunogenicity. A blend of physicochemical, immunological, and toxicological experiments can be used to accurately characterize nanovaccines. This narrative review will provide an overview of the current scenario of the nanovaccine.
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference378 articles.
1. COVID-19 and Vaccination: Myths vs Science;Expert Rev. Vaccines,2022
2. Fenner, F., Henderson, D.A., Arita, I., Jezek, Z., Ladnyi, I.D., and World Health Organization (1988). Smallpox and Its Eradication, World Health Organization.
3. Vaccines Through Centuries: Major Cornerstones of Global Health;Front. Public Health,2015
4. Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development;Cell,2006
5. Nanoparticles and the Environment;J. Air Waste Manag. Assoc.,2005
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献